CLOSE X

Alivus Life Sciences Ltd.

NSE : ALIVUSBSE : 543322ISIN CODE : INE03Q201024Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE987.403.20 (0.33 %)
PREV CLOSE() 984.20
OPEN PRICE () 982.65
BID PRICE (QTY) 0.00(0.00)
OFFER PRICE (QTY) 0.00(0.00)
VOLUME 2374
TODAY'S LOW / HIGH() 959990.85
52 WK LOW / HIGH () 827.101,224.00
ChairmanHiren K Patel
Managing DirectorYasir Rawjee
Company SecretaryRudalf Corriea
Non Executive Independent DirectorKaushikbhai N Patel
Manju Agarwal
TL Easwar
Savan Godiawala
Whole Time DirectorVinod Naik
Incorporation Year : 23-06 2011

Registered Office :

Address : Plot No. 170-172,Chandramouli Industrial Estate,Mohol Bazarpeth Solapur,
Maharashtra-413213 .

Phone : 02189 234456/234246

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

ATTENTION INVESTORS | KYC | IPO

Star Finvest Pvt.Ltd

NEW DELHI:
Corporate / Reg Office

3rd Floor, 311-316 Arunachal Building, 19 Barakhamba Road, New Delhi - 110001

GET DIRECTION
UTTAR PRADESH:
Ghaziabad Branch

Yamnotri Complex, Office No A 12, Ambedkar Rd, Ghaziabad, Uttar Pradesh - 201001

GET DIRECTION
Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html
We believe that an educated investor is a protected investor !!!
SEBI Regn Nos.
NSE CASH INZ 000160735. NSE F&O INZ 000160735. BSE CASH INZ 000160735. BSE F&O INZ 000160735 DP (NSDL) IN-DP-268-2016. MCX INZ 000160735.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.